Up | AC
Home Page
Food and
Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee Meeting
March 30, 2007
FDA
Draft Guidance for Industry for minimally manipulated, unrelated allogeneic cord blood, and the regulatory approach to minimally manipulated unrelated allogeneic peripheral blood stem/progenitor cells (htm)
Bibliography (htm)